eBay
EBAY
Halozyme Therapeutics
HALO
Constellation Brands
STZ
4
Workday
WDAY
5
Lantheus
LNTH
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -0.37%2.99B | -0.27%12.12B | -1.59%3.02B | 2.69%3.05B | 2.15%3.04B | -4.09%3B | -4.62%12.16B | -5.07%3.07B | -11.13%2.97B | -8.31%2.98B |
Operating revenue | -0.37%2.99B | -0.27%12.12B | -1.59%3.02B | 2.69%3.05B | 2.15%3.04B | -4.09%3B | -4.62%12.16B | -5.07%3.07B | -11.13%2.97B | -8.31%2.98B |
Cost of revenue | -34.85%1.74B | -8.48%8.09B | -14.12%1.84B | -17.35%1.74B | -19.90%1.83B | 16.26%2.67B | 17.73%8.84B | 11.95%2.15B | 5.68%2.1B | 21.84%2.29B |
Gross profit | 279.09%1.25B | 21.57%4.04B | 27.40%1.18B | 51.33%1.31B | 74.89%1.21B | -60.34%330M | -36.65%3.32B | -29.77%927M | -35.87%867M | -49.53%693M |
Operating expense | -43.48%39M | -460.55%-393M | -107.25%-143M | -748.15%-350M | -84.21%6M | 2.99%69M | 220.59%109M | 19.77%-69M | 145.45%54M | 0.00%38M |
Selling and administrative expenses | ---- | -2.56%-120M | ---- | ---- | ---- | ---- | 7.14%-117M | ---- | ---- | ---- |
-General and administrative expense | ---- | -2.56%-120M | ---- | ---- | ---- | ---- | 7.14%-117M | ---- | ---- | ---- |
Other operating expenses | -43.48%39M | -220.80%-273M | -147.92%-23M | -748.15%-350M | -84.21%6M | 2.99%69M | 41.25%226M | 20.00%48M | 145.45%54M | 0.00%38M |
Operating profit | 364.37%1.21B | 37.94%4.43B | 32.93%1.32B | 104.43%1.66B | 84.12%1.21B | -65.88%261M | -38.33%3.21B | -29.16%996M | -38.87%813M | -50.94%655M |
Net non-operating interest income expense | 1.00%-199M | -11.77%-807M | -2.05%-199M | -11.54%-203M | -20.00%-204M | -14.86%-201M | -4.34%-722M | -10.17%-195M | -2.82%-182M | 0.00%-170M |
Non-operating interest expense | -1.00%199M | 11.77%807M | 2.05%199M | 11.54%203M | 20.00%204M | 14.86%201M | 4.34%722M | 10.17%195M | 2.82%182M | 0.00%170M |
Other net income (expense) | -16.67%-35M | -73.81%-292M | -31.33%-197M | -88.24%-32M | -163.64%-58M | -1,600.00%-30M | 56.14%-168M | 21.47%-150M | 71.67%-17M | 71.79%-22M |
Special income (charges) | -37.50%-66M | -24.29%-220M | -833.33%-56M | -15.79%-66M | 5.06%-75M | 11.11%-48M | 48.99%-177M | 96.59%-6M | 1.72%-57M | -23.44%-79M |
-Less:Other special charges | 37.50%66M | 24.29%220M | 833.33%56M | 15.79%66M | -16.67%50M | -11.11%48M | -48.99%177M | -96.59%6M | -1.72%57M | -6.25%60M |
-Gain on sale of property,plant,equipment | ---- | ---- | ---- | ---- | -31.58%-25M | ---- | ---- | ---- | ---- | ---19M |
Other non- operating income (expenses) | 72.22%31M | -900.00%-72M | 2.08%-141M | -15.00%34M | -70.18%17M | -67.86%18M | 125.00%9M | -860.00%-144M | 2,100.00%40M | 507.14%57M |
Income before tax | 3,160.00%978M | 43.49%3.33B | 42.55%928M | 132.41%1.43B | 103.89%944M | -94.93%30M | -43.83%2.32B | -37.28%651M | -43.82%614M | -57.41%463M |
Income tax | 1,091.30%228M | 43.41%707M | 57.26%195M | 141.18%328M | 93.46%207M | -118.25%-23M | -42.67%493M | -50.00%124M | 0.74%136M | -60.07%107M |
Net income | 1,315.09%750M | 43.51%2.62B | 39.09%733M | 129.92%1.1B | 107.02%737M | -88.63%53M | -44.13%1.83B | -33.29%527M | -50.10%478M | -56.53%356M |
Net income continuous Operations | 1,315.09%750M | 43.51%2.62B | 39.09%733M | 129.92%1.1B | 107.02%737M | -88.63%53M | -44.13%1.83B | -33.29%527M | -50.10%478M | -56.53%356M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 1,315.09%750M | 43.51%2.62B | 39.09%733M | 129.92%1.1B | 107.02%737M | -88.63%53M | -44.13%1.83B | -33.29%527M | -50.10%478M | -56.53%356M |
Preferred stock dividends | 0.00%1M | 1M | 0.00%1M | 1M | ||||||
Other preferred stock dividends | 0.00%3M | 0.00%3M | ||||||||
Net income attributable to common stockholders | 1,340.38%749M | 43.59%2.62B | 39.16%732M | 130.40%1.1B | 106.74%736M | -88.82%52M | -44.17%1.82B | -33.25%526M | -50.21%477M | -56.48%356M |
Basic earnings per share | 1,339.13%3.31 | 44.03%11.58 | 38.70%3.2388 | 130.33%4.86 | 108.97%3.26 | -88.73%0.23 | -42.24%8.04 | -32.58%2.3352 | -48.66%2.11 | -54.91%1.56 |
Diluted earnings per share | 1,339.13%3.31 | 44.26%11.57 | 39.22%3.23 | 130.95%4.85 | 108.33%3.25 | -88.73%0.23 | -42.22%8.02 | -32.16%2.32 | -48.78%2.1 | -54.78%1.56 |
Dividend per share | 0.00%1.35 | 0.00%5.4 | 0.00%1.35 | 0.00%1.35 | 0.00%1.35 | 0.00%1.35 | 8.87%5.4 | 8.87%1.35 | 8.87%1.35 | 8.87%1.35 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |